Key result
Patients with low asthma-specific medication regimen complexity were nearly four times more likely to adhere to their medication compared to those with high complexity.
Why the study?
Medication adherence is often low in asthma patients with regimen complexity as a potential factor, but data on its relationship to adherence and asthma outcomes were lacking in Ethiopian patients.
Does medication regimen complexity affect medication adherence and asthma control in patients with asthma?
Cross-Sectional (n=396)
Yes
Does medication regimen complexity affect medication adherence and asthma control in patients with asthma?
Lower medication regimen complexity is significantly associated with better medication adherence and improved asthma control in patients with asthma.
Answers are grounded in this paper and cite their sources.
May support simplifying regimens to boost adherence; leaves open causal effects on control in prospective trials.
BACKGROUND: Various studies have found that medication adherence is generally low among patients with asthma, and that the complexity of the regimen may be a potential factor. However, there is no information on the complexity of the regimen and its relationship to adherence and asthma outcomes in Ethiopian asthma patients. Therefore, this study assessed how complex medication regimens affected medication adherence and asthma control in patients with asthma. METHOD: From February 1 to May 30, 2022, a multicenter cross-sectional study was conducted in three public referral hospitals in northwestern Ethiopia. The Medication Complexity Index (MRCI), a 65-item validated instrument, was used to represent the complexity of medication regimens The Medication Adherence Rating Scale for Asthma (MARS-A) was used to assess medication adherence, and the ACT was used to measure the level of asthma control. The association between predictor and outcome variables was determined using multivariable logistic regression analysis. P-values of < 0.05 were declared as a significant association. RESULT: Patients with asthma (n = 396) who met the inclusion criteria were included in the final analysis. About 21.2% and 24.5% of the participants had high asthma-specific MRCI and patient-level MRCI, respectively. The majority (84.4%) of the participants did not adhere to their medication, and 71% of the participants were classified as having uncontrolled asthma. According to the result of the multivariable analysis, moving from a high asthma-specific MRCI to a moderate asthma MRCI enhances the likelihood of medication adherence by 2.51 times (AOR = 2.51, 95%CI: (1.27, 7.71). Likewise, patients who have low asthma MRCI were four times more likely to adhere to the medication compared with high asthma MRCI (AOR = 3.80, 95%CI: (2.0, 11.1). Similarly, patients having low patient-level MRCI were eight times more likely their asthma level had been controlled (AOR = 7.84, 95%CI: 1.46 to 21.3) and patients who had moderate patient-level MRCI were three times (AOR = 2.83, 95%CI: 1.05 to 8.25) more controlled asthma compared with patients who had high patient level MRCI. CONCLUSION: The majority of asthma patients had low and moderate complexity of MRCI. Patients with low and moderate regimen complexity demonstrated high adherence and had well-controlled asthma. Therefore, future researchers should consider MRCI as one factor for adherence and asthma control levels.
No takes yet. Share an insight, caveat, or question.
Belachew et al. (2022) conducted a cross-sectional in Asthma (n=396). Low asthma-specific medication regimen complexity vs. High asthma-specific medication regimen complexity was evaluated on Medication adherence (AOR 3.80, 95% CI 2.0-11.1, p=0.033). Patients with low asthma-specific medication regimen complexity were nearly four times more likely to adhere to their medication compared to those with high complexity.
Synapse has enriched 10 related papers. Consider them for comparative context: